BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23835602)

  • 1. Computationally designed prodrugs of statins based on Kirby's enzyme model.
    Karaman R; Amly W; Scrano L; Mecca G; Bufo SA
    J Mol Model; 2013 Sep; 19(9):3969-82. PubMed ID: 23835602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrugs of aza nucleosides based on proton transfer reaction.
    Karaman R
    J Comput Aided Mol Des; 2010 Dec; 24(12):961-70. PubMed ID: 20941527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-assisted design of pro-drugs for antimalarial atovaquone.
    Karaman R; Hallak H
    Chem Biol Drug Des; 2010 Oct; 76(4):350-60. PubMed ID: 20731669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-assisted design for paracetamol masking bitter taste prodrugs.
    Hejaz H; Karaman R; Khamis M
    J Mol Model; 2012 Jan; 18(1):103-14. PubMed ID: 21491187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and in vitro kinetics study of atenolol prodrugs for the use in aqueous formulations.
    Karaman R; Qtait A; Dajani KK; Abu Lafi S
    ScientificWorldJournal; 2014; 2014():248651. PubMed ID: 24526887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-assisted design for atenolol prodrugs for the use in aqueous formulations.
    Karaman R; Dajani K; Hallak H
    J Mol Model; 2012 Apr; 18(4):1523-40. PubMed ID: 21785934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodrugs of acyclovir--a computational approach.
    Karaman R; Dajani KK; Qtait A; Khamis M
    Chem Biol Drug Des; 2012 May; 79(5):819-34. PubMed ID: 22260647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural mechanism for statin inhibition of HMG-CoA reductase.
    Istvan ES; Deisenhofer J
    Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Istvan ES
    Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins in therapy: understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies.
    Fong CW
    Eur J Med Chem; 2014 Oct; 85():661-74. PubMed ID: 25128668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking.
    Karthik MV; Satya Deepak MV; Shukla P
    Comput Biol Med; 2012 Feb; 42(2):156-63. PubMed ID: 22177940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach.
    Silva M; Philadelpho B; Santos J; Souza V; Souza C; Santiago V; Silva J; Souza C; Azeredo F; Castilho M; Cilli E; Ferreira E
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme Models-From Catalysis to Prodrugs.
    Breijyeh Z; Karaman R
    Molecules; 2021 May; 26(11):. PubMed ID: 34071328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations.
    Son M; Baek A; Sakkiah S; Park C; John S; Lee KW
    PLoS One; 2013; 8(12):e83496. PubMed ID: 24386216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of new druggable sites in the anti-cholesterol target HMG-CoA reductase by computational alanine scanning mutagenesis.
    Gesto DS; Cerqueira NM; Ramos MJ; Fernandes PA
    J Mol Model; 2014 Apr; 20(4):2178. PubMed ID: 24671303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the inhibitor effects of bergamot juice flavonoids binding to the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) enzyme.
    Leopoldini M; Malaj N; Toscano M; Sindona G; Russo N
    J Agric Food Chem; 2010 Oct; 58(19):10768-73. PubMed ID: 20843083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric inhibitors of HMG-CoA reductase, the key enzyme involved in cholesterol biosynthesis.
    Haber A; Abu-Younis Ali A; Aviram M; Gross Z
    Chem Commun (Camb); 2013 Dec; 49(93):10917-9. PubMed ID: 23958894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computationally designed atovaquone prodrugs based on Bruice's enzyme model.
    Karaman R; Fattash B; Mecca G; Bader M
    Curr Comput Aided Drug Des; 2014 Mar; 10(1):15-27. PubMed ID: 24138416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding thermodynamics of statins to HMG-CoA reductase.
    Carbonell T; Freire E
    Biochemistry; 2005 Sep; 44(35):11741-8. PubMed ID: 16128575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteopedia entry: HMG-CoA reductase.
    Canner D
    Biochem Mol Biol Educ; 2011; 39(1):64. PubMed ID: 21433257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.